首页|基于TLR4/MyD88/MAPK信号通路探讨脉络舒通丸抗血栓性浅静脉炎的作用机制研究

基于TLR4/MyD88/MAPK信号通路探讨脉络舒通丸抗血栓性浅静脉炎的作用机制研究

扫码查看
[目的]探讨脉络舒通丸抗血栓性浅静脉炎(STP)的作用机制.[方法]将36只日本大耳白兔随机分为正常组、模型组、脉络舒通丸低、中、高剂量组、地奥司明组(阳性药对照),每组 6 只.除正常组外,其余各组均采用耳缘静脉注射20%甘露醇建立STP兔模型.造模同时各给药组连续灌胃给药14 d.苏木精-伊红(HE)染色法检测各组兔耳组织病理变化;酶联免疫吸附(ELISA)法检测各组血清中白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的水平;测定凝血 4 项;蛋白免疫印迹(Western Blot)法检测耳组织Toll样受体 4(TLR4)、髓样分化因子 88(MyD88)、细胞外信号调节激酶(ERK1/2)、p38 丝裂原活化蛋白激酶(p38MAPK)和c-氨基酸末端激酶(JNK)蛋白表达及相关磷酸化水平.[结果]与正常组比较,模型组病理损伤评分显著增加(P<0.01);血清中IL-1β、TNF-α和IL-6 的表达水平明显升高(P<0.05);活化部分凝血酶时间(APTT)、凝血酶原时间(PT)、凝血酶时间(TT)缩短,纤维蛋白原(FIB)含量升高(P<0.05);TLR4、MyD88、丝裂原活化蛋白激酶(MAPK,包括p38MAPK、ERK1/2 和JNK)蛋白及相关磷酸化水平均显著上调(P<0.01).与模型组比较,脉络舒通丸低、中、高剂量组、地奥司明组兔耳组织病理损伤显著改善,病理损伤评分明显降低(P<0.05 或P<0.01);血清中IL-1β、TNF-α和IL-6 的表达水平显著降低(P<0.05或P<0.01);APTT、PT、TT明显延长,FIB含量明显降低(P<0.05或P<0.01);TLR4、MyD88、MAPK(p38MAPK、ERK1/2和JNK)蛋白及相关磷酸化水平均显著下调(P<0.05 或P<0.01).[结论]脉络舒通丸可能通过抑制TLR4/MyD88/MAPK信号通路,减轻炎症反应,改善凝血功能,从而发挥抗血栓性浅静脉炎作用.
Mechanism of Mailuo Shutong Pill on anti-superficial thrombophlebitis based on TLR4/MyD88/MAPK signaling pathway
[Objective]To investigate the mechanism of Mailuo Shutong Pill on superficial thrombophlebitis.[Methods]A total of 36 Japanese white rabbits were randomly divided into normal group,model group,low,medium,high dose of Mailuo Shutong Pill group,and positive drug(Diosmin)group,with 6 rabbits in each group.Except the normal group,the rabbit model of superficial thrombophlebitis was established by injecting 20%mannitol into bilateral auricular vein of other groups.At the same time,the treated groups were respectively administrated through gavage once a day for 14 consecutive days.Pathological changes of rabbit ear tissue were detected by hematoxylin and eosin(HE)staining.The levels of interleukin-1β(IL-1β),tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)in serum were detected by enzyme-linked immunosorbent assay(ELISA).The semi-automatic hemagglutination analyzer was used to measure indicators of coagulation function.Expressions levels of toll-like receptor 4(TLR4)and myeloid differentiation factor 88(MyD88)were detected by western blotting.The protein expression and phosphorylation level of extracellular signal-regulated kinase(ERK1/2),p38 mitogen-activated protein kinase(p38MAPK)and c-amino acid terminal kinase(JNK)were detected by western blotting.[Results]The model group demonstrated increase in pathological injury score(P<0.01),significant decline in serum content of inflammatory factors IL-1β,TNF-α and IL-6(P<0.05);shortened activated partial thromboplastin time,prothrombin time(PT),and thrombin time(TT),while increased fibrinogen(FIB)content(P<0.05);increased the protein expression and the phosphorylation levels of TLR4,MyD88,MAPK(p38MAPK,ERK1/2 and JNK,P<0.01)compared with the normal group.While Mailuo Shutong Pill significantly reduced the score of pathological injury and improved the pathological injury of ear tissue(P<0.05 or P<0.01);significantly decreased the expression levels of IL-1β,TNF-α and IL-6 in serum(P<0.05 or P<0.01);prolonged APTT,PT and TT and decreased FIB content(P<0.05 or P<0.01);down-regulated the protein expression and phosphorylation level of TLR4,MyD88,MAPK(p38MAPK,ERK1/2 and JNK,P<0.05 or P<0.01)compared with the model group.[Conclusion]Mailuo Shutong Pill was able to inhibit the inflammatory response and improve blood coagulation function in a model rabbit with superficial thrombophlebitis,and the mechanism may be related to the inhibition of TLR4/MyD88/MAPK signaling pathway activation.

Mailuo Shutong Pillsuperficial thrombophlebitisTLR4/MyD88/MAPK signaling pathwaymechanism

王清果、曹宁宁、李市荣、张琬靖、孙成宏、姚景春、张贵民、肖学凤

展开 >

天津中医药大学中药学院,天津 301617

天津中医药大学第二附属医院,天津 300250

鲁南制药集团股份有限公司新药药理中心,临沂 276000

国家癌症中心,国家肿瘤临床医学研究中心,河北中国医学科学院肿瘤医院,廊坊 065001

展开 >

脉络舒通丸 血栓性浅静脉炎 TLR4/MyD88/MAPK信号通路 作用机制

国家自然科学基金项目天津市自然科学基金重点项目释药技术与药代动力学国家重点实验室(天津药物研究院)开发课题资助项目

8197355720JCZDJC00010010162001

2024

天津中医药大学学报
天津中医药大学

天津中医药大学学报

CSTPCD
影响因子:1.324
ISSN:1673-9043
年,卷(期):2024.43(1)
  • 35